vs
DHI GROUP, INC.（DHX）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是DHI GROUP, INC.的1.1倍（$35.5M vs $31.4M），DHI GROUP, INC.净利率更高（3.0% vs -304.2%，领先307.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -9.8%），DHI GROUP, INC.自由现金流更多（$5.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -6.7%）
DHI集团是总部位于丹麦的国际水环境企业，业务涵盖水环境软件开发与工程咨询，拥有自主水环境建模软件MIKE Powered by DHI，同时为客户提供商业应用、数据门户、运营服务等全链条水环境解决方案。集团目前在全球设有30个分支机构，在新加坡和丹麦都设有研发中心，全球员工约1050名。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
DHX vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.4M | $35.5M |
| 净利润 | $951.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 10.4% | -304.8% |
| 净利率 | 3.0% | -304.2% |
| 营收同比 | -9.8% | 681.7% |
| 净利润同比 | -6.9% | 39.6% |
| 每股收益（稀释后） | $0.03 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $31.4M | $35.5M | ||
| Q3 25 | $32.1M | $5.2M | ||
| Q2 25 | $32.0M | $19.2M | ||
| Q1 25 | $32.3M | $14.7M | ||
| Q4 24 | $34.8M | $4.5M | ||
| Q3 24 | $35.3M | $26.1M | ||
| Q2 24 | $35.8M | $14.4M | ||
| Q1 24 | $36.0M | $13.8M |
| Q4 25 | $951.0K | $-108.1M | ||
| Q3 25 | $-4.3M | $-162.3M | ||
| Q2 25 | $-841.0K | $-171.9M | ||
| Q1 25 | $-9.4M | $-202.5M | ||
| Q4 24 | $1.0M | $-178.9M | ||
| Q3 24 | $-200.0K | $-95.8M | ||
| Q2 24 | $943.0K | $-97.5M | ||
| Q1 24 | $-1.5M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | 85.7% | -183.8% | ||
| Q2 25 | 84.0% | -4.9% | ||
| Q1 25 | 83.4% | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | 85.6% | 53.7% | ||
| Q2 24 | 85.5% | 36.2% | ||
| Q1 24 | 86.5% | 19.1% |
| Q4 25 | 10.4% | -304.8% | ||
| Q3 25 | -14.0% | -3327.6% | ||
| Q2 25 | -3.9% | -916.8% | ||
| Q1 25 | -27.5% | -1297.9% | ||
| Q4 24 | 5.0% | -4042.4% | ||
| Q3 24 | 1.8% | -377.1% | ||
| Q2 24 | 5.6% | -697.4% | ||
| Q1 24 | 5.5% | -698.4% |
| Q4 25 | 3.0% | -304.2% | ||
| Q3 25 | -13.3% | -3135.3% | ||
| Q2 25 | -2.6% | -894.2% | ||
| Q1 25 | -28.9% | -1373.3% | ||
| Q4 24 | 2.9% | -3935.5% | ||
| Q3 24 | -0.6% | -367.5% | ||
| Q2 24 | 2.6% | -676.6% | ||
| Q1 24 | -4.2% | -662.4% |
| Q4 25 | $0.03 | $-0.17 | ||
| Q3 25 | $-0.10 | $-0.36 | ||
| Q2 25 | $-0.02 | $-0.41 | ||
| Q1 25 | $-0.21 | $-0.50 | ||
| Q4 24 | $0.02 | $-0.56 | ||
| Q3 24 | $0.00 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $-0.03 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $94.5M | $1.1B |
| 总资产 | $188.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $2.9M | $743.3M | ||
| Q3 25 | $2.3M | $659.8M | ||
| Q2 25 | $2.8M | $525.1M | ||
| Q1 25 | $2.7M | $500.5M | ||
| Q4 24 | $3.7M | $594.4M | ||
| Q3 24 | $2.1M | $427.6M | ||
| Q2 24 | $3.0M | $474.3M | ||
| Q1 24 | $3.2M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $30.0M | $11.9M | ||
| Q2 25 | $30.0M | $14.2M | ||
| Q1 25 | $33.0M | $16.4M | ||
| Q4 24 | $32.0M | $19.0M | ||
| Q3 24 | $32.0M | $20.5M | ||
| Q2 24 | $35.0M | $22.9M | ||
| Q1 24 | $41.0M | — |
| Q4 25 | $94.5M | $1.1B | ||
| Q3 25 | $97.3M | $1.0B | ||
| Q2 25 | $102.5M | $919.1M | ||
| Q1 25 | $103.9M | $933.9M | ||
| Q4 24 | $114.3M | $1.0B | ||
| Q3 24 | $111.3M | $524.6M | ||
| Q2 24 | $109.8M | $584.4M | ||
| Q1 24 | $106.6M | $401.2M |
| Q4 25 | $188.2M | $1.5B | ||
| Q3 25 | $192.5M | $1.4B | ||
| Q2 25 | $204.9M | $1.3B | ||
| Q1 25 | $212.1M | $1.3B | ||
| Q4 24 | $221.4M | $1.4B | ||
| Q3 24 | $219.4M | $726.5M | ||
| Q2 24 | $224.4M | $775.9M | ||
| Q1 24 | $231.9M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.31× | 0.01× | ||
| Q2 25 | 0.29× | 0.02× | ||
| Q1 25 | 0.32× | 0.02× | ||
| Q4 24 | 0.28× | 0.02× | ||
| Q3 24 | 0.29× | 0.04× | ||
| Q2 24 | 0.32× | 0.04× | ||
| Q1 24 | 0.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 18.1% | -133.1% |
| 资本支出强度资本支出/营收 | 4.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 7.60× | — |
| 过去12个月自由现金流最近4个季度 | $13.8M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $7.2M | $-46.1M | ||
| Q3 25 | $4.8M | $-117.4M | ||
| Q2 25 | $6.9M | $-76.4M | ||
| Q1 25 | $2.2M | $-132.0M | ||
| Q4 24 | $4.4M | $-115.4M | ||
| Q3 24 | $5.5M | $-59.2M | ||
| Q2 24 | $9.1M | $-82.2M | ||
| Q1 24 | $2.1M | $-102.3M |
| Q4 25 | $5.7M | $-47.3M | ||
| Q3 25 | $3.2M | $-117.6M | ||
| Q2 25 | $4.8M | $-79.6M | ||
| Q1 25 | $88.0K | $-133.8M | ||
| Q4 24 | $1.6M | $-116.7M | ||
| Q3 24 | $2.3M | $-63.8M | ||
| Q2 24 | $5.6M | $-83.4M | ||
| Q1 24 | $-2.4M | $-109.0M |
| Q4 25 | 18.1% | -133.1% | ||
| Q3 25 | 9.9% | -2272.5% | ||
| Q2 25 | 15.1% | -413.9% | ||
| Q1 25 | 0.3% | -907.4% | ||
| Q4 24 | 4.6% | -2567.7% | ||
| Q3 24 | 6.5% | -244.6% | ||
| Q2 24 | 15.6% | -578.5% | ||
| Q1 24 | -6.5% | -789.9% |
| Q4 25 | 4.9% | 3.5% | ||
| Q3 25 | 5.0% | 4.7% | ||
| Q2 25 | 6.3% | 16.4% | ||
| Q1 25 | 6.7% | 12.4% | ||
| Q4 24 | 8.0% | 28.6% | ||
| Q3 24 | 9.2% | 17.5% | ||
| Q2 24 | 9.7% | 8.2% | ||
| Q1 24 | 12.3% | 48.2% |
| Q4 25 | 7.60× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.61× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHX
| Clearance Jobs | $17.4M | 56% |
| Clearance Jobs Segment | $13.9M | 44% |
RXRX
暂无分部数据
